Publication | Open Access

Design, synthesis and pharmacological evaluation of 2-(thiazol-2-amino)-4-arylaminopyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors

Medicinal ChemistryMedicineRational Drug DesignPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacological EvaluationPharmacologyRadiation OncologyDrug Discovery